Candel Therapeutics, Inc. · NASDAQ:CADL
BlackRock, Inc. reported a 5.20% stake in Candel Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.20% stake in Candel Therapeutics, Inc., 2,859,610 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 2,859,610
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.20% | 2,859,610 |
Source
Related
- Candel Therapeutics, Inc.
- BlackRock, Inc.
- Candel Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Form 4 · Tyagarajan Seshu · Jul 1, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026